BioPharma Dive1d
Moderna gets $590M from US government for bird flu vaccine
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
TipRanks on MSN6d
Shionogi Secures BARDA Funding for Long-Acting COVID-19 Antiviral Development
Shionogi & Co. has been awarded a $375 million project agreement by the Biomedical Advanced Research and Development ...
Business Wire9d
PopVax is Awarded 2 Million USD as One of the Winners of the BARDA Patch Forward Prize for its Seasonal Influenza Vaccine built on a Novel mRNA-encoded Immunogen Display ...
PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.
UMass Lowell1y
Biomedical Advanced Research and Development Authority (BARDA)
Established in 2006, the mission of the BARDA is to develop and procure medical countermeasures, vaccines, drugs, therapeutics, diagnostic tools, and nonpharmaceutical products, that address the ...
Nasdaq3d
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab
Moderna MRNA announced that the U.S. government, through the Biomedical Advanced Research and Development Authority (“BARDA”), has awarded the company $590 million to accelerate the ...
Joplin Globe9d
Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for Vaccination
Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for Vaccination ...
Bioxytran Announces Government Interest After Initial BARDA Techwatch Light Meeting
Bioxytran presented four key Areas of Interest (AOI): an influenza antiviral, immune modulators for lung repair, solutions for uncontrolled hemorrhaging, and a versatile strategic therapeutic. The ...